Marshak Richard's most recent trade in TriSalus Life Sciences Inc was a trade of 561 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on June 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 3.87 per share. | 30 Jun 2026 | 561 | 128,319 | - | 3.9 | 2,171 | Common Stock |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.67 per share. | 15 May 2026 | 543 | 125,101 | - | 2.7 | 1,450 | Common Stock |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 4.09 per share. | 11 Mar 2026 | 1,589 | 110,816 | - | 4.1 | 6,499 | Common Stock |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 4.13 per share. | 11 Mar 2026 | 1,449 | 112,405 | - | 4.1 | 5,984 | Common Stock |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 4.12 per share. | 11 Mar 2026 | 419 | 110,397 | - | 4.1 | 1,726 | Common Stock |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | 31 Dec 2025 | 999 | 35,404 | - | 4.3 | 4,256 | Common Stock | |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | 31 Dec 2025 | 930 | 71,309 | - | 4.2 | 3,934 | Common Stock | |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | 31 Dec 2025 | 449 | 131,758 | - | 4.4 | 1,967 | Common Stock | |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | 31 Dec 2025 | 279 | 27,530 | - | 4.7 | 1,309 | Common Stock | |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Nov 2025 | 120,000 | 408,937 | - | - | Employee Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Nov 2025 | 60,000 | 113,854 | - | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 5.18 per share. | 19 May 2025 | 21,428 | 75,698 | - | 5.2 | 110,997 | Common Stock |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.18 per share. | 19 May 2025 | 6,597 | 69,101 | - | 5.2 | 34,172 | Common Stock |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 7,644 | 54,270 | - | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,500 | 46,626 | - | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Richard Marshak | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 41,250 | 41,250 | - | - | Employee Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | Richard Marshak | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 6,875 | 34,126 | - | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | Richard Marshak | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 14,752 | 27,251 | - | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | Richard Marshak | Sr.VP, Corp. Dev. & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) |